Bath & Body Works (NYSE:BBWI - Get Free Report) updated its fourth quarter 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 1.410-1.610 for the period, compared to the consensus estimate of 1.720. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion. Bath & Body Works also updated its FY 2026 guidance to 2.600-2.800 EPS.
Bath & Body Works Stock Up 1.5%
Bath & Body Works stock opened at $18.68 on Thursday. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $24.94. The firm's fifty day moving average is $19.21 and its 200 day moving average is $19.78. The company has a market capitalization of $3.77 billion, a PE ratio of 4.86, a PEG ratio of 0.92 and a beta of 1.31.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.14. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Sell-side analysts expect that Bath & Body Works will post 2.74 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date of this dividend is Friday, November 20th. Bath & Body Works's dividend payout ratio is 20.83%.
Analyst Upgrades and Downgrades
BBWI has been the subject of several research reports. Morgan Stanley reduced their target price on Bath & Body Works from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 27th. JPMorgan Chase & Co. upped their price target on Bath & Body Works from $22.00 to $24.00 and gave the stock a "neutral" rating in a research note on Tuesday, August 18th. Argus reiterated a "hold" rating on shares of Bath & Body Works in a report on Wednesday, September 16th. Jefferies Financial Group raised their price objective on Bath & Body Works from $22.00 to $23.00 and gave the company a "hold" rating in a research note on Tuesday, July 28th. Finally, Citigroup raised Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 target price on the stock in a research report on Tuesday, August 18th. Four equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $22.53.
Read Our Latest Research Report on Bath & Body Works
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.